Skip to main content
OpenTrials

Clinical trial condition

Mastocytosis, Systemic

Explore clinical trials studying Mastocytosis, Systemic. Study availability and eligibility vary by location and protocol.

39 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Mastocytosis, Systemic trial results

Completed

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

NCT02561988

Conditions
Aggressive Systemic Mastocytosis, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study of Mast Cell Precursors

NCT00001756

Conditions
Healthy Volunteer, Immune System Diseases, Mast Cell Activation Disorders, +6 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

NCT04695431

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Standford Cancer Center Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Medizinische Universitat Wien Vienna, Austria
  • Universitatmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
View Trial Details
Completed

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

NCT00109707

Conditions
Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Bone Marrow Diseases, Chronic Disease, +27 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt Tampa, Florida, United States
View all 101 locations
View Trial Details
Completed

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

NCT00814073

Conditions
Albinism, Amino Acid Metabolism, Inborn Errors, Behavior, +28 more
Locations
  • UC Davis Health System , Department of Dermatology Sacramento, California, United States
  • MD Anderson Cancer Centre Houston, Texas, United States
  • CHU d'Amiens Amiens, France
  • Hôpital Avicenne Bobigny, France
View all 24 locations
View Trial Details
Completed

Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis

NCT02441166

Conditions
Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +11 more
Locations
  • CHU Bordeaux Hôpital Haut-Lévêque, service de dermatologie Bordeaux, France
  • CHU de Caen, service d'hématologie Caen, France
  • CHU Dupuytren service d'hématologie Limoges, France
  • CHU Lyon Sud, service de médecine interne Lyon, France
View Trial Details

Related conditions